Chris Tolles

Email me




Cambridge, Massachusetts,

United States


Sundots are the world’s first gummy for sun protection.

We all know that sun exposure is the #1 cause of skin cancer and the #1 cause of skin aging. The bad news? Sunscreen, while super-important, just isn’t enough - we’re not getting the protection we need.

Sundots are based on the active ingredient polypodium leucotomos, a fern extract from Ecuador backed by 30+ years of research for sun protective properties, including blinded human clinical trials done at Harvard.

We raised over $100,000 in our launch campaign on Indiegogoin March 2018 (more than 500% our goal) and are currently producing our first manufacturing run of Sundots slated for delivery to our Indiegogo backers and new customers in June 2018.


publication logo

New York Post

These gummies can help protect against sunburns

Hannah Sparks – May 21st, 2018

publication logo

WCVB-TV Boston

Cutting Edge: Sun protection in a gummy

Mike Wankum – April 6th, 2018


Chris edit xl

Chris Tolles

CEO + Co-Founder

Chris Tolles is a consumer healthcare entrepreneur focused on compelling brands that address meaningful challenges in health and wellness. A designer by training, Chris received his BFA from Rhode Island School of Design (RISD), and his MBA from Boston University. Prior to Sundots, Chris helped large companies identify new markets, products, and business models at Innosight, an innovation and growth consultancy co-founded by Harvard Business School Professor Clay Christensen. Chris formerly led product at One Earth Designs, a solar social venture in China, and is a Thomas J Watson Fellow.

Emilia edit xl crop

Dr. Emilia Javorsky, MD, MPH

Chief Scientific Officer + Co-Founder

Emilia Javorsky MD, MPH is a physician-scientist focused on developing new tools to improve health and well being. Emilia received her undergraduate degree from Columbia University, her masters from Boston University, her medical degree from the University of Massachusetts, and completed her post-doctoral research in dermatology at Massachusetts General Hospital. Emilia was a Fulbright-Schuman scholar to the European Union, where she studied methods of accelerating medical innovation. Currently, she is also involved in early-stage life science ventures and leads an Artificial Intelligence in Medicine initiative with the Future Society. She is a TEDx speaker, was honored as part of the Forbes 30 Under 30 Class of 2017 in Healthcare, and is a member of the World Economic Forum's Global Shaper community.